Denali Therapeutics DNLI
NASDAQ DNLI
$18.41 -0.25 (-1.34%)
At close: Oct 23, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Cash & Current Investments (2017 - 2026)

Updated

Denali Therapeutics' Cash & Current Investments came in at $710.47 million for Q2 2026, down 21.0% from $898.95 million a year earlier and down 28.1% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, Denali Therapeutics' Cash & Current Investments was $867.88 million, up 4.3% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $832.33 million in FY2024 (-19.5%), $1.03 billion in FY2023 (-22.6%), $1.34 billion in FY2022 (+54.4%) and $865.41 million in FY2021 (-41.1%).
  • The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q2 2020.
  • Year-over-year, Cash & Current Investments increased in four of the last eight quarters, with an average decline of 6.4%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2022 (growth of 54.4%), and the weakest in Q4 2021 (a decline of 41.1%).
  • Business Quant data shows DNLI's Cash & Current Investments at $987.68 million (Q1 2026), $867.88 million (Q4 2025) and $848.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Denali Therapeutics 3.46 Bn 43.59 Mn 3.51 Mn 710.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 710.47 Mn
Mar 31, 2026 987.68 Mn
Dec 31, 2025 867.88 Mn
Sep 30, 2025 848.20 Mn
Jun 30, 2025 898.95 Mn
Mar 31, 2025 817.93 Mn
Dec 31, 2024 832.33 Mn
Sep 30, 2024 836.56 Mn
Jun 30, 2024 896.04 Mn
Mar 31, 2024 936.87 Mn
Dec 31, 2023 1.03 Bn
Sep 30, 2023 1.11 Bn
Jun 30, 2023 1.19 Bn
Mar 31, 2023 1.29 Bn
Dec 31, 2022 1.34 Bn
Sep 30, 2022 1.11 Bn
Jun 30, 2022 1.07 Bn
Mar 31, 2022 957.52 Mn
Dec 31, 2021 865.41 Mn
Sep 30, 2021 1.04 Bn
API Access

Denali Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DNLI&period=max&api_key=YOUR_API_KEY